| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/23/1999 | WO1999047517A1 Novel heterocyclic compounds |
| 09/23/1999 | WO1999047156A2 Compositions for modulating cell differentiation comprising a lipid and a morphogen |
| 09/23/1999 | WO1999047154A1 Dipeptide caspase inhibitors and the use thereof |
| 09/23/1999 | WO1999047145A1 Use of sphingosin-1-phosphate, sphingosin-1-phosphate derivatives and/or mixtures thereof for the treatment of inflammatory diseases of the skin |
| 09/23/1999 | WO1999047141A1 Method of treating skin irritation |
| 09/23/1999 | WO1999047140A1 Topical antiseptic compositions and methods |
| 09/23/1999 | WO1999047133A1 Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage |
| 09/23/1999 | WO1999047112A1 Method of reducing cellulite in mammalian skin |
| 09/23/1999 | WO1999039682A3 Lipid mixtures and their use |
| 09/23/1999 | WO1998015284A3 Mycosis vaccines |
| 09/23/1999 | DE19812059C1 Diaminobenzol-Derivate sowie diese Diaminobenzol-Derivate enthaltende Haarfärbemittel Diaminobenzene derivatives, and this diaminobenzene derivatives containing hair dyes |
| 09/23/1999 | CA2323887A1 Use of sphingosin-1-phosphate, sphingosin-1-phosphate derivatives and/or mixtures thereof for the treatment of inflammatory diseases of the skin |
| 09/23/1999 | CA2323439A1 Dipeptide caspase inhibitors and the use thereof |
| 09/23/1999 | CA2323179A1 Method of reducing cellulite in mammalian skin |
| 09/23/1999 | CA2323095A1 Metal-containing ribonucleotide polypeptides |
| 09/23/1999 | CA2323078A1 Compositions for modulating cell differentiation comprising a lipid and a morphogen |
| 09/23/1999 | CA2322994A1 Topical antiseptic compositions and methods |
| 09/23/1999 | CA2322795A1 Metal-containing ribonucleotide polypeptides |
| 09/23/1999 | CA2322742A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 09/23/1999 | CA2266601A1 Solid deodorant composition |
| 09/22/1999 | EP0943616A1 Substituted imidazole derivatives and their use as cytokine inhibitors |
| 09/22/1999 | EP0943614A2 Dyeing agents comprising diaminobenzene derivatives and the diaminobenzene derivatives |
| 09/22/1999 | EP0943334A1 Tortoise oil, turtle oil, compositions containing them, their preparation processes and uses |
| 09/22/1999 | EP0943327A1 Medicinal composition |
| 09/22/1999 | EP0943323A1 Cosmetic or dermatological composition containing at least a natural or recombinant arachnida silk protein or an analogue |
| 09/22/1999 | EP0943322A1 Use of a cosmetic composition to prevent and treat the rosacea |
| 09/22/1999 | EP0943320A1 Process for oxidative dyeing and composition for oxidative dyeing of keratinic fibres comprising a cationic amphiphilic polymer |
| 09/22/1999 | EP0943311A2 Method of inhibiting hair growth |
| 09/22/1999 | EP0942974A2 Secreted proteins and polynucleotides encoding them |
| 09/22/1999 | EP0942915A1 Pharmaceutical formulations |
| 09/22/1999 | EP0942724A2 Gel formulations for topical drug delivery |
| 09/22/1999 | EP0726764B1 Multilamellar liposomal arachidonic acid metabolite formulations |
| 09/22/1999 | EP0517836B1 Method and product for promoting hair growth and treating skin conditions |
| 09/22/1999 | CN1229407A Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing the same |
| 09/22/1999 | CN1229357A Method of inhibiting fibrosis with growth inhibition excitant |
| 09/22/1999 | CN1228986A Burn ointment |
| 09/22/1999 | CN1228983A Mongolian medicine prescription for treating skin disease and preparation method thereof |
| 09/22/1999 | CN1228972A Medicine for treating burn |
| 09/22/1999 | CN1228970A Traditional Chinese medicine for treating skin disease and veneral disease |
| 09/22/1999 | CN1228956A Cosmetic cream and production method thereof |
| 09/22/1999 | CN1045160C Hair growth modification |
| 09/21/1999 | US5955593 BH3 interacting domain death agonist |
| 09/21/1999 | US5955578 Synthetic matrix of synthetic polypeptide including amino acid sequence of d-arginine-glycine-aspartic acid, a biodegradable polymer, and optional crosslinking agent; temporary wound healing agent which promotes cell migration |
| 09/21/1999 | US5955492 Carboxylic acid indole inhibitors of chemokines |
| 09/21/1999 | US5955476 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels |
| 09/21/1999 | US5955462 Antiinflammatory agents for neurogenic inflammation and administering bisindole or compounds |
| 09/21/1999 | US5955455 Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 09/21/1999 | US5955430 Use of angiotensin II fragments and analogs thereof in tissue repair |
| 09/21/1999 | US5955260 Antibodies that bind viral proteins that share homogeneity; for diagnostic immunoassay of virus in sample |
| 09/21/1999 | US5955092 Skin care compositions containing an n-substituted fatty acid amide and retinol or retinyl ester |
| 09/21/1999 | US5955091 Photobluing/whitening-resistant cosmetic/dermatological compositions comprising TiO2 pigments and deformable hollow particulates |
| 09/21/1999 | US5955083 Use of eriobotrya japonica extract, in particular in cosmetics for stimulating glycosaminoglycan synthesis |
| 09/21/1999 | US5955081 Antipsoriatic compositions, method of making, and method of using |
| 09/21/1999 | US5955078 Novel polypeptides and monoclonal antibodies, preparation and use to combat infection at the site of wounds, surgical implants and other in-dwelling devices such as catheters |
| 09/21/1999 | US5955059 Treating psoriasis, other skin disorders |
| 09/21/1999 | CA2086429C Pharmaceutical or cosmetic composition containing a combination of a retinoid and a sterol |
| 09/16/1999 | WO1999046364A1 Vascular endothelial growth factor 2 |
| 09/16/1999 | WO1999046289A1 31 human secreted proteins |
| 09/16/1999 | WO1999046280A1 Lipid compounds derived from sphingoid bases, preparation method and uses in cosmetics and dermopharmacy |
| 09/16/1999 | WO1999046279A2 INHIBITORS OF TYPE 5 AND TYPE 3 17β-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE |
| 09/16/1999 | WO1999046268A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 09/16/1999 | WO1999046248A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| 09/16/1999 | WO1999046237A1 Modulators of protein tyrosine phosphatases |
| 09/16/1999 | WO1999045974A1 Protease inhibitors in absorbent articles |
| 09/16/1999 | WO1999045973A1 Disposable absorbent article having a skin care composition containing an enzyme inhibitor |
| 09/16/1999 | WO1999045938A1 Thrombin preparation and products and fibrin sealant methods employing same |
| 09/16/1999 | WO1999045933A1 Novel delivery of hydroxy carboxylic acids |
| 09/16/1999 | WO1999045919A1 Phenanthrofuran derivatives |
| 09/16/1999 | WO1999045909A2 Use of nitrone compounds for the inhibition of angiogenesis |
| 09/16/1999 | WO1999045900A1 Skin normalizing agents |
| 09/16/1999 | WO1999045770A1 Skin equivalent and methods of forming and using same |
| 09/16/1999 | WO1999035243A3 Extension of cellular lifespan, methods and reagents |
| 09/16/1999 | WO1999029878A3 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
| 09/16/1999 | WO1999015657A3 53bp2 complexes |
| 09/16/1999 | WO1999011249A3 Use of endipalene in the treatment of psoriasis |
| 09/16/1999 | DE19810999A1 Use of sphingosine compounds to treat inflammatory skin disorders, especially psoriasis, acne and dermatoheliosis |
| 09/16/1999 | CA2332114A1 Novel delivery of hydroxy carboxylic acids |
| 09/16/1999 | CA2323493A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 09/16/1999 | CA2323490A1 inhibition of angiogenesis |
| 09/16/1999 | CA2323451A1 Skin conditioner |
| 09/16/1999 | CA2323089A1 Inhibitors of type 5 and type 3 17.beta.-hydroxysteroid dehydrogenase and methods for their use |
| 09/16/1999 | CA2322962A1 Phenanthrofuran derivatives |
| 09/16/1999 | CA2322748A1 Vascular endothelial growth factor 2 |
| 09/16/1999 | CA2322741A1 Thrombin preparation and products and fibrin sealant methods employing same |
| 09/16/1999 | CA2322728A1 31 human secreted proteins |
| 09/16/1999 | CA2322503A1 Disposable absorbent article having a skin care composition containing an enzyme inhibitor |
| 09/16/1999 | CA2321216A1 Lipid compounds derived from sphingoid bases, preparation method and uses in cosmetics and dermopharmacy |
| 09/15/1999 | EP0942001A1 Sphingoid Lipid Compounds, a Process for Their Production and Cosmetic and Dermopharmaceutical uses Thereof |
| 09/15/1999 | EP0941354A1 Syndecan enhancer element and its use for targeting gene expression |
| 09/15/1999 | EP0941330A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 09/15/1999 | EP0941247A2 Peptide compounds useful for modulating fgf receptor activity |
| 09/15/1999 | EP0941108A1 Wound healing and treatment of fibrosis |
| 09/15/1999 | EP0941105A1 Pretraumatic use of hemoglobin |
| 09/15/1999 | EP0941089A2 Compositions and methods for treating or preventing inflammatory diseases |
| 09/15/1999 | EP0941056A1 Sphingomyelinase compositions and use thereof |
| 09/15/1999 | EP0941054A1 Use of sterolsulfates as active substances for producing means to inhibit serin proteases |
| 09/15/1999 | EP0850065B1 Transdermal therapeutical system for silatran compounds |
| 09/15/1999 | EP0741697B1 Amino acid derivatives and their use as phospholipase a2 inhibitors |
| 09/15/1999 | CN1228780A Phosphinic acid amides as matrix metalloprotease inhibitors |
| 09/15/1999 | CN1228779A Spirocyclic metalloprotease inhibitors |